Olema reports Q3 2026 results, reiterates early-2027 OPERA-01 data timelineNov 16Regulatory decisionOlema Pharmaceuticals, Inc.palazestrant
Novartis posts Cosentyx nail psoriasis and imatinib results; Piqray label updatedOct 30Weekly roundup, 8 itemsalpelisibeverolimusUpdated
Wave Life Sciences details Q3 2026 progress on WVE-006, WVE-007, WVE-008 pipelineOct 28Quarterly updateBristol Myers SquibbEli LillyUpdated
Novartis updates Zortress label; advances Fanconi anemia and IgAN trialsSep 16Weekly roundup, 4 itemsatrasentaneltrombopag
Novartis updates Leqvio label; MS study recruiting, thyroid study not yet recruitingAug 21Weekly roundup, 8 itemsGIA632inclisiran
Novartis: Myfortic label update approved; M.D. Anderson posts endometrial trial resultsJul 31Weekly roundup, 6 itemsabelacimabDDY391